Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK

INTRODUCTION: Patients with type 2 diabetes mellitus (T2DM) who fail to meet glycaemic control are at increased risk of diabetes complications. For patients who cannot maintain glycaemic control with oral medication, one recommended option is to add an injectable glucagon-like peptide-1 receptor ago...

Descripción completa

Detalles Bibliográficos
Autores principales: Boye, Kristina S., Stein, Dara, Matza, Louis S., Jordan, Jessica, Yu, Ren, Norrbacka, Kirsi, Hassan, Syed Wasi, García-Pérez, Luis-Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544605/
https://www.ncbi.nlm.nih.gov/pubmed/31115873
http://dx.doi.org/10.1007/s40268-019-0273-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544605/
https://www.ncbi.nlm.nih.gov/pubmed/31115873
http://dx.doi.org/10.1007/s40268-019-0273-0

Ejemplares similares